SHAWN FADUM: Open Payments
NPI 1013374271 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 47 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $1,527
Food & beverage: $1,455Education: $72
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $367 |
| CSL Behring | 12 | $268 |
| GENZYME CORPORATION | 8 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $152 |
| Regeneron Healthcare Solutions, Inc. | 4 | $117 |
| Blueprint Medicines Corporation | 2 | $114 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $75 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Grifols USA, LLC | 2 | $34 |
Products named: DUPIXENT, Hizentra, CUVITRU, AYVAKIT, BREZTRI, TEZSPIRE, AIRSUPRA, NEFFY.
Industry payments across OK — which companies pay providers there.
